Sponsored Sessions

Sponsored Sessions

Sunday, 17 March 2013, from 17:45 to 19:15 - Location: Brown Hall 1-2 - Level S2

Silodosin: A first choice for the pharmacological treatment of BPH

Sponsored by RECORDATI
Opening remarks
F. Montorsi, Milan (IT)
BPH: Where we are today
F.C. Hamdy, Oxford (GB)
Which patient and why - An analysis of pooled data from the phase III studies in EU and US
H. Lepor, New York (US)
Which patient and why - An analysis of pooled date from the phase III studies in EU and US
G. Novara, Padova (IT)
The 'real life' profile of the BPH patient
H. Botto, Suresnes (FR)
Clinical cases and discussion
F. Montorsi, Milan (IT)

Sunday, 17 March 2013, from 17:45 to 19:15 - Location: Amber Hall 1-2 - Level S2

Burden of illness and optimal management of recurrent cystitis

Sponsored by OM PHARMA SA
Introduction
K.G. Naber, Straubing (DE)
Antimicrobial susceptibility and resistance in urological infections worldwide: Surveillance and prevention
F.M.E. Wagenlehner, Gießen (DE)
Guidelines in urinary tract infections (UTI): The place of immunoactive-prophylaxis in recurrent UTI management
K.G. Naber, Straubing (DE)
Burden of illness of recurrent UTI: Clinical benefit of oral immunostimulation and impact on patients' quality of life
B. Wullt, Lund (SE)
Responders profile and evidence in clinical practice
P. Tenke, Budapest (HU)
Panel Discussion
This site uses cookies. Read more about our privacy policy.